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Standardized extractAbstract The methanolic extract of the leaves of Liquidambar styraciflua L. (Altingiaceae) (LSE)
was evaluated for hepatoprotective and antioxidant activities in carbon tetrachloride liver-damaged
rats. Hepatotoxicity was induced via intraperitoneal injection of CCl4 1:9 in olive oil, at a dose of
0.5 ml/kg b.wt. The animals received the extract, orally, at two dose levels (250 and 500 mg/kg
b.wt.) The administration regimen was twice a week, for six consecutive weeks. LSE exhibited a sig-
niﬁcant dose-dependent protective effect by lowering the serum levels of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), malondialdehyde (MDA)
and ameliorating the level of serum protein. In addition, LSE showed antioxidant activity through
improving the levels of blood glutathione (GSH), vitamin C, vitamin E and hepatic total protein
contents. The LSE revealed activity approached that of silymarin, a known hepatoprotective agent.
These biochemical observations were supported by examination of the histopathological features of
the liver. Chromatographic fractionation of LSE afforded seven phenolic compounds. These were
identiﬁed on the basis of chromatographic, chemical and spectroscopic analyses as: gallic acid (1),
isorugosin B (2), casuarictin (3), quercetin-3-O-b-D-4C1-glucopyranoside (4), myricetin-3-O-a-L-
1C4-
rhamnopyranoside (myricetrin) (5), quercetin (6) and myricetin (7). The isolated phenolics probably
account for the antioxidant and hepatoprotective effects exhibited by the parent extract.
Furthermore, a validated RP-HPLC method was devised for standardization of LSE, in view to
fulﬁll the requirements of efﬁcient research methodology for evaluation of bioactive herbal drugs.
118 H.H. Eid et al.The above ﬁndings suggested that LSE could be considered as a standardized herbal product with
antiﬁbrotic, hepatoprotective and antioxidant potential.
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Liver disease is considered a global problem especially in
developing countries including Egypt. Hepatitis, viral infec-
tions, food additives, alcohol, toxic industrial chemicals, air
and water pollutants are the major risk factors of liver toxic-
ity.1 Treatment of liver diseases via synthetic medication is usu-
ally disappointing, due to severe undesirable effects produced
on prolonged administration. Therefore, herbal products had
gained more interest in this issue and recent studies aimed at
characterizing the health promoting properties of many plants,
especially those rich in phenolics known to possess remarkable
antioxidant and hepatoprotective potencies.
Liquidambar (Sweetgum) is a genus of four species of ﬂow-
ering plants belonging to family Altingiaceae.2 Numerous stud-
ies have been conducted on both chemical composition and
bioactivities of its members. Several types of phytoconstituents
have been isolated namely; tannins,3–5 iridoids,6 ﬂavonoids,7,8
di- and triterpenoids.9–13 Reports on the biological activities
were concerned with wound healing,14 anti-ulcerogenic,15
antifungal,16 antimicrobial and antioxidant17,18 effects.
Regarding Liquidambar styraciﬂua L., earlier studies on its
secondary metabolites reported the isolation of gallic and
ellagic acids,19 shikimic acid20,21 as well as triterpenoids.22
Moreover, its cytotoxic,23 cancer chemopreventive24,25 and
antihypertensive26 effects have been evaluated. In a previous
publication, the authors investigated the inﬂuence of seasonal
variation on the chemical composition, antioxidant and anti-
inﬂammatory activities of the leaf and stem essential oils.27
In Taiwan, the related species Liquidambar formosana is tradi-
tionally claimed to be useful for management of hepatitis;
besides, its antihepatotoxic activity has been evidenced.11
Yet, data concerning either the in vivo antioxidant potential
or hepatoprotective effect of L. styraciﬂua are lacking. In addi-
tion, plants of family Altingiaceae are known to be enriched in
polyphenols, which owing to their antioxidant effect, exert a
wide variety of biological potentialities.
The current study was thus planned in view to evaluate the
antioxidant and hepatoprotective activities of the methanolic
extract of the leaves of L. styraciﬂua, naturalized in Egypt,
against CCl4-induced hepatic damage in rats, as well as, to iso-
late and identify its components. Furthermore and in compli-
ance with research protocols for assessment of herbal drugs, a
standardization procedure based on quantitative reversed
phase-high performance chromatography (RP-HPLC) was
developed and validated to estimate the amount of bioactive
principles.2. Materials and methods
2.1. Plant material
Leaves of L. styraciﬂua L. were collected, in December 2010,
from Alzohreya Botanical Garden, Cairo, Egypt. The plantwas kindly authenticated by Agricultural Engineer Therese
Labib (Herbarium Section, Orman Garden, Giza, Egypt)
and Dr. Mohamed El Gebali (Plant Taxonomy and Egyptian
Flora Department, National Research Center, Dokki, Giza,
Egypt). Voucher specimen of the plant material was deposited
at the herbarium of the Department of Pharmacognosy,
Faculty of Pharmacy, Cairo University (PHE.1217-1224).
2.2. Plant extract
Air-dried powdered leaves of L. styraciﬂua (4 kg) were exhaus-
tively extracted by percolation, at 50 C, with 80% methanol
(3 · 6 L). The resulting extract was evaporated under vacuum,
at a temperature not exceeding 40 C, until almost free from
methanol. The ﬁnal concentrate was then subjected to
lyophilization to yield a dry greenish brown powder (93.4 g).
The dried L. styraciﬂua methanolic extract (LSE) was then
carefully saved in a dark brown tightly closed container for
further biological and phytochemical investigation.
2.3. Chemicals and biochemical kits
Folin–Ciocalteu reagent, gallic acid, quercetin, sodium carbon-
ate, vitamin E and vitamin C were purchased from Sigma
Chemicals Co. (St. Louis, MO, USA). All chemicals and sol-
vents were of analytical grade. Polyamide 6 for column chro-
matography was obtained from Reidal-De Haen AG (Seezle
Hannover, Germany). The following biochemical kits were
purchased from their respective sources: Glutathione kit
(Wak-Chemie Medical, Germany) and Transaminase kits
(BioMerieux Co.) were used for the assessment of serum ala-
nine aminotransferase (ALT), aspartate aminotransferase
(AST) and alkaline phosphatase (ALP) enzymes.
2.4. Experimental animals
Male Wistar albino rats (100–120 g) were obtained from the
Animal House, National Research Center (NRC), Egypt. All
animals were kept in a controlled environment of air and tem-
perature with access to water and diet ad libitum. Anesthetic
procedures and animal handling were in compliance with the
ethical guidelines of Medical Ethics Committee of the
National Research Centre in Egypt and performed to ensure
that animals did not suffer at any stage of the experiment
(Approval No. #10031).
2.5. Biological study
2.5.1. Acute toxicity study
Three groups of rats (8 rats, each) were examined for the acute
toxicity of the plant extract. One oral dose of LSE at concen-
trations of 250, 500 and 1000 mg/kg b.wt. was administered to
rats. The mortality rate was calculated 24 h after administra-
tion of LSE. Only one dead animal was observed after 24 h
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selected to conduct this study; 250 and 500 mg/kg b.wt.
2.5.2. Experimental design28,29
LSE (15 g) was suspended in 0.5% carboxy methyl cellulose
(CMC) in distilled water at the appropriate concentration
prior to oral treatment. The administration regimen was twice
a week for six consecutive weeks. Fifty-six male Wistar albino
rats were divided into seven groups (8 animals, each).
Group 1 (normal control): was orally treated with the vehi-
cle (0.5 ml CMC) and received 0.5 ml olive oil by i.p. injection.
Groups 2 and 3 (normal healthy): received LSE, orally, at
two different doses 250 and 500 mg/kg b.wt., and were i.p.
injected with 0.5 ml olive oil.
Group 4 (CCl4 group): was orally ingested with the vehicle
(0.5 ml CMC) and i.p. injected with 0.5 ml/kg b.wt. CCl4 (in
olive oil 1:9 v/v).
Groups 5 and 6: were given LSE, orally, at 250 and
500 mg/kg b.wt.; and forced with 0.5 ml/kg b.wt. CCl4 at the
same time, for the same duration.
Group 7 (Silymarin): was treated, orally, with silymarin
(100 mg/kg b.wt.) and forced with CCl4 (0.5 ml/kg b.wt. i.p.)
at the same time, for the same duration.
2.5.3. Sample preparation
Blood samples were collected from the animal, by puncturing
the sublingual vein, in clean and dry test tubes, left 10 min to clot
and centrifuged at 3000 rpm (4 C) for serum separation. The
separated serumwas stored at80 C for further determination
of liver function enzymes. Liver tissue was divided into two por-
tions. The ﬁrst portion was used for histopathological examina-
tion and the second was homogenized in normal physiological
saline solution (0.9%NaCl) (1:9 w/v). The homogenatewas cen-
trifuged at 4 C for 5 min at 3000 rpm and the supernatant used
for estimation of hepatic oxidative stress markers.
2.5.4. Biochemical assays
2.5.4.1. Oxidative stress markers. The serum level of malondi-
aldehyde, as a product of polyunsaturated fatty acid oxidation
was determined spectrophotometrically, at 535 nm.30
Glutathione was assayed using dithiobis-2-nitrobenzoic acid
(DTNB) in PBS, and color absorbance measured at
412 nm.31 Vitamin C was estimated using Folin reagent; mea-
surements were done at 760 nm.32 Vitamin E was determined
colorimetrically based on measuring the intensity of the pink
colored complex produced by reacting ferrous ions with
bathophenanthroline, at 536 nm.33
2.5.4.2. Serum biomarkers for liver function tests. Aspartate
and alanine aminotransferase (AST and ALT) activities were
measured according to Gella et al.34; whereas, alkaline phos-
phatase (ALP) was determined by adopting the procedure of
Rosalki et al.35
2.5.4.3. Serum and hepatic total protein content. Total protein
was assayed based onwhich Coomassie Brilliant Blue dye reacts
with Bradford reagent giving a blue complex at 595 nm.36
2.5.4.4. Histopathological examination. Liver slices were ﬁxed
in 10% paraformaldehyde and embedded in parafﬁn wax
blocks. Sections of 5 lm thick were stained with hematoxylin& eosin (H&E) and Masson’s trichrome, then examined under
a light microscope for the determination of pathological
changes.37
2.5.4.5. Statistical analysis. All data were expressed as
mean ± SD of eight rats in each group. Statistical analysis
that was carried out by one way analysis of variance
(ANOVA) among various treatments was followed by the least
signiﬁcance difference (LSD) test at p< 0.05. SPSS ver. 14.0
(Chicago, IL, USA) was used for the statistical calculation:
%Change¼ control mean treated mean=control mean100:
%Improvement ¼ treated mean injured mean=control mean 100:2.6. Phytochemical investigation
2.6.1. Determination of total phenolic content
Total phenolic content was determined using Folin–Ciocalteu
reagent.38 Absorption was measured, at 760 nm, by means of
HP 8451 spectrophotometer (Hewlett-Packard, Cambridge,
UK) and compared to gallic acid calibration curve. Results
were expressed as mg gallic acid equivalents (GAE)/g extract.
Each assay was carried out in triplicate.
2.6.2. Extraction, isolation and identiﬁcation of phenolics
Fractionation of LSE (65 g) was done on a polyamide 6 col-
umn (200 g, 100 cm · 5.5 cm) by eluting with distilled H2O,
followed by gradients of H2O and MeOH. Fractions (200–
500 ml) were collected into 12 main fractions (I–XII). The
compounds within subfractions II (1.02 g), V (0.3 g) and XII
(1.5 g) were separated through repeated preparative paper
chromatography over Whatmann No. 3 MM using the appro-
priate developing system (n-butanol:acetic acid:water (4:1:5,
v/v, BAW, upper layer). Sub-fraction II (eluted with 40%
MeOH) yielded three major compounds: 1 (42 mg), 2
(35 mg) and 3 (26 mg); while subfraction V (eluted with 60%
MeOH) yielded two compounds (4, 26 mg) and (5, 20 mg);
and ﬁnally subfraction XII (eluted with MeOH) afforded
two major compounds 6 (37 mg) and 7 (28 mg). All com-
pounds were identiﬁed by conventional analytical methods
(qualitative chromatography and UV spectroscopy) and con-
ﬁrmed through 1H and 13C NMR spectral data.
2.6.3. RP-HPLC standardization of LSE
2.6.3.1. Sample preparation. An accurately weighed amount of
LSE (0.1078 g) was introduced into a 20 ml volumetric ﬂask.
The sample was sonicated and the volume adjusted with
MeOH (w/v). All sample solutions were ﬁltered through
0.45 lm membrane ﬁlter into sample vials and degassed,
before HPLC analysis.
2.6.3.2. Construction of the standard calibration curves.
Standard stock solutions of gallic acid and quercetin were pre-
pared by weighing accurately and dissolving in MeOH to ﬁnal
concentrations of 1.28 and 0.12 mg/ml, respectively. The stock
solutions were serially diluted for preparation of ﬁnal concen-
tration ranges of 0.128–0.512 mg/ml for gallic acid and 0.012–
0.048 mg/ml for quercetin. Standard calibration curves were
established based on four concentrations. Each sample was
repeated in triplicates.
120 H.H. Eid et al.2.6.3.3. HPLC analysis39. HPLC analysis was performed on
Agilent instrument (Agilent technologies, USA) equipped with
quaternary pump G1311A, vacuum degasser G1322A, stan-
dard preparative autosampler G1329A with an injection vol-
ume of 20 ll and Diode Array and multiple wavelength
detector (Agilent technologies) as well as a reverse phase
ZORBAX Eclipse XDB-C18 column (4.6 · 150 mm, 5 lm)
and a ZORBAX Eclipse XDB-C18 guard column
(4.6 · 12.5 mm, 5 lm).
The mobile phase consisted of MeOH (Solvent A) and
AcOH in H2O, 1:25 (Solvent B). The gradient elution program
began with 100% B for 4 min, 50% A for 6 min, 80% A for
10 min and then A was reduced to 50% again for 2 min.
Total run time was 22 min. The ﬂow rate was 0.6 ml/min.
The detection was made at 280 nm and 330 nm. Data were
processed using Chemstation 4.02 software.
2.6.3.4. Validation of the quantiﬁcation method 40.
2.6.3.4.1. Linearity. Linearity was determined for the
calibration curves obtained by HPLC analysis on four
concentrations (0.128–0.512 mg/ml for gallic acid andTable 2 Effect of the methanolic extract of Liquidambar stryaciﬂua
Parameters Control Control treated
(250 mg/kg
b.wt.)
Control treated
(500 mg/kg
b.wt.)
CCl4
GSH 6.64 ± 3.50a 7.06 ± 0.65a 7.09 ± 0.58a 4.49
– (+6.32) (+6.77) (32
MDA 6.75 ± 0.50d 6.94 ± 0.43c,d 6.73 ± 0.53d 8.48
– (+2.81) (+0.29) (+25
Vitamin C 4.36 ± 0.31a,b 4.58 ± 0.46a 4.69 ± 0.16b,c 2.93
– (+5.04) (+7.56) (-32.
Vitamin E 7.72 ± 0.48a 7.17 ± 0.23b 7.73 ± 0.46b 5.62
– (7.12) (7.12) (27
All values are means ± SD of eight rats in each group. Data are expresse
MDA.
Unshared letters between groups are the signiﬁcance values at p< 0.05;
Statistical analysis is carried out using one way analysis of variance (A
p< 0.05.
Table 1 Intra-day and inter-day precision of the developed
RP-HPLC method for determination of polyphenolics in the
methanolic extract of L. styraciﬂua L.
Parameter Gallic acid Quercetin
Content* RSD
(%)
Content* RSD
(%)
Intra-day
a
68.419 ± 0.0107 2.9012 0.9297 ± 0.00040 0.7905
Inter-day
b
68.777 ± 0.0134 3.6150 0.9264 ± 0.00020 3.9924
Stability c 68.386 ± 0.0146 3.9667 0.9373 ± 0.00019 3.7336
* Mean ± SD (mg/g extract).
a Sample analyzed ﬁve times during one day, (n= 6).
b Sample analyzed each day over three consecutive days, (n= 9).
c Sample analyzed at 0, 2, 4, 7, 24, 48 h (n= 6).0.012–0.048 mg/ml for quercetin). The correlation coefﬁcients
were calculated by the linear regression method.
2.6.3.4.2. Precision. A sample was prepared as previ-
ously described and analyzed six times on the same day
to evaluate intra-daily variation and on three consecutive
days to assess inter-daily variation (nine measurements).
The precision was expressed as relative standard deviation
(RSD%).
2.6.3.4.3. Accuracy. The accuracy was tested by separate
spiking with a known amount of the standard gallic acid
(1.1 mg) and quercetin (2.6 mg) to the extract samples and ana-
lyzed in triplicates. The average recovery was calculated
according to the formula: Recovery (%) = [(net measured
amount  original amount)/spiked amount] · 100.
2.6.3.4.4. Limit of detection (LOD) and limit of quantitation
(LOQ)41. Limit of detection (LOD) and limit of quantitation
(LOQ) were determined according to the International
Conference on Harmonization Guidelines and calculation
was based on the standard deviation of the response (r) and
the slope of the calibration curve (S). LOD= 3.3 * r/S and
LOQ= 10 * r/S.
2.6.3.4.5. Stability. Stability was evaluated by analyzing the
same sample at 0, 2, 4, 7, 24 and 48 h after its preparation.
3. Results and discussion
3.1. Biological study
With respect to the oxidative stress markers, healthy control
rats showed insigniﬁcant changes in GSH, MDA, vitamin C
and E (Table 2). A signiﬁcant decrease in GSH, vitamin C
and E was observed in CCl4-injured rats by 32.37%,
32.79% and 27.20%, respectively; while MDA was signiﬁ-
cantly increased by 25.62%. Rats treated with 250 mg/kg
b.wt. of LSE exhibited amelioration in GSH, MDA, vitamins
C and E levels by 13.70%, 9.62%, 18.57% and 14.77%, respec-
tively. Administration of higher doses of LSE (500 mg)
resulted in better improvement of all parameters (by 19.42%,
20.59%, 20.64% and 16.45%, respectively). Meanwhile,
administration of silymarin (reference herbal hepatoprotective)L. on oxidative stress markers in normal and CCl4 treated rats.
CCl4 treated
(250 mg/kg
b.wt.)
CCl4 treated
(500 mg/kg
b.wt.)
CCl4 treated
with
silymarin
p<
± 0.56b 5.40 ± 0.44c 5.78 ± 0.48c 5.97 ± 0.03c 0.0001
.37) (18.67) (12.95) (10.09)
± 0.58a 7.83 ± 0.34c,d 7.09 ± 0.46b 7.42 ± 0.34b,c 0.0001
.62) (+16.00) (+5.03) (+9.92)
± 0.30c 3.74 ± 0.19c 3.83 ± 0.38c 3.74 ± 0.18c 0.003
79) (14.22) (12.15) (14.22)
± 0.55b 6.76 ± 0.57b 6.89 ± 0.49b 6.79 ± 0.22b 0.0001
.20) (12.43) (10.75) (12.04)
d as lg/mg protein for GSH, Vit. C, Vit. E and lmol/mg protein for
values between brackets are percentage change over control group.
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T
a
b
le
3
E
ff
ec
t
o
f
th
e
m
et
h
a
n
o
li
c
ex
tr
a
ct
o
f
L
iq
u
id
a
m
b
a
r
st
ry
a
ci
ﬂ
u
a
L
.
o
n
li
v
er
fu
n
ct
io
n
en
zy
m
es
,
se
ru
m
a
n
d
ti
ss
u
e
p
ro
te
in
in
n
o
rm
a
l
a
n
d
C
C
l 4
tr
ea
te
d
ra
ts
.
P
a
ra
m
et
er
s
C
o
n
tr
o
l
C
o
n
tr
o
l
tr
ea
te
d
(2
5
0
m
g
/k
g
b
.w
t.
)
C
o
n
tr
o
l
tr
ea
te
d
(5
0
0
m
g
/k
g
b
.w
t.
)
C
C
l 4
C
C
l 4
tr
ea
te
d
(2
5
0
m
g
/k
g
b
.w
t.
)
C
C
l 4
tr
ea
te
d
(5
0
0
m
g
/k
g
b
.w
t.
)
C
C
l 4
tr
ea
te
d
w
it
h
si
ly
m
a
ri
n
p
<
A
S
T
2
.9
0
±
0
.1
5
b
2
.8
5
±
0
.1
6
b
2
.8
6
±
0
.1
5
b
4
.2
0
±
0
.1
7
a
2
.9
6
±
0
.2
3
b
2
.9
3
±
0
.2
1
b
2
.9
8
±
0
.1
9
b
0
.0
0
7
8
–
(
1
.7
5
)
(
1
.3
7
)
(+
4
4
.8
2
)
(+
2
.0
7
)
(+
1
.0
3
)
(+
2
.7
5
)
A
L
T
2
.0
2
±
0
.1
3
b
c
2
.0
0
±
0
.0
7
b
1
.8
8
±
0
.0
3
c
2
.5
3
±
0
.1
3
a
2
.1
9
±
0
.2
4
b
2
.1
4
±
0
.0
3
b
2
.0
4
±
0
.3
3
b
,c
0
.0
0
0
1
–
(
0
.9
9
)
(
6
.9
3
)
(+
2
5
.2
5
)
(+
8
.4
1
)
(+
5
.9
4
)
(+
0
.9
9
)
A
L
P
1
1
6
.7
2
±
1
4
.1
1
c
1
0
8
.6
0
±
9
.8
8
d
1
0
1
.8
0
±
3
.3
4
d
1
5
8
.0
0
±
5
.2
4
a
1
3
8
.8
0
±
6
.9
7
b
1
3
5
.8
0
±
1
0
.0
0
b
1
3
4
.2
0
±
3
.7
6
b
0
.0
0
0
1
–
(6
.9
5
)
(
1
2
.7
8
)
(+
3
5
.3
6
)
(+
1
8
.9
1
)
(+
1
6
.3
4
)
(+
1
4
.9
7
)
S
er
u
m
p
ro
te
in
1
.6
3
±
0
.0
3
b
,c
1
.7
3
±
0
.0
6
b
1
.6
8
±
0
.0
5
c
1
.9
3
±
0
.1
7
a
1
.6
9
±
0
.1
1
b
1
.6
7
±
0
.0
6
b
1
.6
5
±
0
.1
4
b
,c
0
.0
0
0
5
–
(+
6
.1
3
)
(+
3
.0
6
)
(+
1
8
.4
0
)
(+
3
.6
8
)
(+
2
.4
5
)
(+
1
.2
2
)
T
is
su
e
p
ro
te
in
6
0
.8
0
±
3
.1
9
c
6
1
.2
0
±
1
.9
2
a
6
4
.0
0
±
2
.3
4
a
5
2
.4
0
±
4
.6
0
c
5
6
.6
0
±
2
.7
0
d
5
8
.2
0
±
4
.2
1
b
5
7
.6
0
±
2
.3
0
c
,d
0
.0
0
0
1
–
(+
0
.6
5
)
(+
5
.2
6
)
(
1
3
.8
1
)
(
6
.9
1
)
(
4
.2
7
)
(
5
.2
6
)
A
ll
v
a
lu
es
a
re
m
ea
n
s
±
S
D
o
f
ei
g
h
t
ra
ts
in
ea
ch
g
ro
u
p
;
d
a
ta
a
re
ex
p
re
ss
ed
a
s
U
n
it
/L
(A
S
T
,
A
L
T
,
A
L
P
);
m
g
/m
l
(s
er
u
m
p
ro
te
in
);
m
g
/g
li
v
er
(t
is
su
e
p
ro
te
in
).
U
n
sh
a
re
d
le
tt
er
s
b
et
w
ee
n
g
ro
u
p
s
a
re
th
e
si
g
n
iﬁ
ca
n
ce
v
a
lu
es
a
t
p
<
0
.0
5
;
v
a
lu
es
b
et
w
ee
n
b
ra
ck
et
s
a
re
p
er
ce
n
ta
g
e
ch
a
n
g
e
o
v
er
co
n
tr
o
l
g
ro
u
p
.
S
ta
ti
st
ic
a
l
a
n
a
ly
si
s
is
ca
rr
ie
d
o
u
t
u
si
n
g
o
n
e
w
a
y
a
n
a
ly
si
s
o
f
v
a
ri
a
n
ce
(A
N
O
V
A
),
C
o
S
ta
t
C
o
m
p
u
te
r
P
ro
g
ra
m
a
cc
o
m
p
a
n
ie
d
w
it
h
L
S
D
te
st
a
t
p
<
0
.0
5
.
Hepatoprotective and antioxidant activities of Liquidambar styraciﬂua L. 121led to amelioration by 22.28%, 15.70%, 18.57% and 15.16%
of GSH, MDA, and vitamins C and E levels, respectively.
The liver function enzymes (Table 3) demonstrated insignif-
icant changes following the treatment of control healthy rats
with either 250 or 500 mg/kg b.wt. of LSE. Meanwhile,
CCl4-injured rats showed a signiﬁcant increase in AST, ALT
and ALP enzyme activity by 44.82%, 25.24% and 35.36%,
respectively. Treatment of CCl4-injured rats with LSE at
250 mg/kg b.wt. reduced the elevated AST, ALT and ALP
activities by 42.76%, 16.83% and 16.45%, respectively.
Moreover, treatment with LSE at 500 mg/kg b.wt. showed bet-
ter amelioration (by 43.79%, 19.30% and 19.02%, respec-
tively). In comparison the standard drug, silymarin, lowered
enzymatic activities by 42.07%, 24.26% and 20.39% for
AST, ALT and ALP, respectively.
Serum and hepatic total protein contents were insigniﬁ-
cantly changed in normal rats treated with both LSE doses
(Table 3). Obviously, CCl4-injured rats demonstrated a signif-
icant increase in serum protein content by 18.40%, while that
of hepatic protein was signiﬁcantly reduced by 13.81%.
Treatment with 250 mg of LSE ameliorated serum and hepatic
protein levels by 14.72% and 6.90%, respectively; this
improvement was raised (15.95% and 9.54%, respectively)
by increasing the dose to 500 mg LSE. On the other hand, sily-
marin administration improved serum protein by 17.18%, and
hepatic total protein by 8.55%.
Histological analysis of liver sections of normal control rats
showed normal hepatic lobular architecture. The hepatocytes
were within normal limits and arranged in thin plates; they
were separated by narrow blood sinusoids lined by endothelial
cells. Portal tracts extended with no ﬁbrous tissue or lympho-
cyte deposition (Fig. 2a and b). Healthy rats treated with
LSE (250 and 500 mg/kg b.wt.) showed normal hepatic lobular
architecture. The hepatocytes were within normal limits and
neither hydropic nor steatosis changes were observed. Portal
tracts were normal and with no sign of ﬁbrosis (Fig. 2c–f).
Liver injured with CCl4 showed portal loss of hepatic lob-
ular architecture. Ballooning of hepatocytes, deformed cord
arrangement and disturbed sinusoids were seen. The hepato-
cytes showed a marked degree of hydropic and steatotic
changes, and massive necrosis. Portal tracts were extended
with marked numbers of chronic inﬂammatory cells and
ﬁbrous tissue. There were portoportal and portocentral ﬁbrosis
(Fig. 3a and b). Treatment of injured liver with LSE
(250 mg/kg b.wt.) partly preserved the hepatic normal archi-
tecture; mild degrees of steatosis and hydropic changes were
recorded; the hepatocytes were still swollen with narrow sinu-
soids; and portal tracts were extended with the appearance of
moderate ﬁbrous tissue (Fig. 3c and d). Treatment with LSE
at the higher dose (500 mg/kg b.wt.) showed well-formed
nucleated hepatocytes arranged in cord with obvious sinu-
soidal arrays; minimal fat vacuoles and inﬂammatory lympho-
cyte inﬁltrations were observed (Fig. 3e and f). Treatment
with silymarin showed swelling and foamy appearance of hep-
atocytes (Fig. 3g and h); besides, hydropic and steatosis
changes and ﬁbrotic tissues were obviously seen.
Carbon tetrachloride (CCl4) is a potent environmental hep-
atotoxin; it enhances the formation of free radicals through
bioactivation in phase I of the cytochrome P450 system to
form the reactive metabolic trichloromethyl radical (CCl3)
and trichloromethyl peroxy radical (OOCCl3) which can bind
with polyunsaturated fatty acids to generate lipid peroxides
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Figure 1 Structures of the phenolic compounds isolated from the methanolic extract of Liquidambar styraciﬂua L.
122 H.H. Eid et al.and ROS that induce injury or necrosis with corresponding
health problems.42,43 Moreover, CCl4 is known to decrease
glutathione (GSH) of phase II enzymes and to reduce antiox-
idant enzymes and substrates resulting in induction of oxida-
tive stress, which is an important factor in acute and chronic
injuries in various tissues.44 Consequently, the accumulated
free radicals could further stimulate lipid peroxidation process
and therefore increase malondialdehyde content. The observed
decrease in GSH activity might be due to a decrease in avail-
ability of GSH produced during enhanced lipid peroxidation
processes. Treatment of CCl4 injured rats with LSE signiﬁ-
cantly ameliorated the disturbed GSH and MDA contents thus
supporting the role of the plant extract as antioxidant and free
radical scavenger.
As regards vitamin C and coinciding with the present ﬁnd-
ings, Frei et al.45 reported that peroxyl radicals are trapped by
ascorbate resulting in a decrease in the level of both enzyme
and vitamin during the free radical scavenging process.
Similarly, the reduction of vitamin E as a result of oxidative
stress is due to that the vitamin acts as a soluble antioxidant
to protect biological membranes against oxidative stress which
leads to maintenance of cell function.46
The signiﬁcant rise in ALT, AST and ALP subsequent to
CCl4 intoxication reﬂected the rise in enzyme activities
28,43,47
due to an increase in hepatic cell membrane fragility that led
to enzyme release into circulation. These enzymes, being cyto-
plasmic in location, are released into the circulation after auto-
lytic breakdown or cellular necrosis due to the damaged
structural integrity of the liver.
According to Romero et al.48, CCl4 intoxication induced
changes in the process of protein synthesis. Hence, increasein serum total protein content can be considered as a useful
index of the severity of cellular dysfunction in liver diseases.
This was obvious in the present study, where hepatic protein
level was decreased and its serum concentration increased.
Stimulation of protein synthesis has been advanced as a con-
tributory self-healing mechanism, which accelerates liver
regeneration process49.
In conclusion, treatment with the methanolic extract of L.
styraciﬂua L. noticeably attenuated the increased level of
serum enzymes and caused a subsequent recovery toward nor-
malization. This gives an additional support that this extract is
able to: condition the hepatocytes, accelerate regeneration of
parenchyma cells, protect against membrane fragility and
decrease leakage of enzymes into circulation.
Histopathological studies revealed that CCl4 induced exten-
sive fatty change, blood vessel congestion, cellular hypertrophy
and inﬁltration, necrotic foci, destruction of the lobular archi-
tecture, ﬁbrosis, and nuclear degeneration in some areas.43
This was in accordance with the present ﬁndings reﬂected as
massive deformation of hepatic cells architecture after CCl4
induction. Treatment with LSE ameliorated the hepatocyte
degeneration forms where necrosis and inﬁltration of inﬂam-
matory cells were all in fact ameliorated. Minimal deposition
of fat vacuoles and mild ﬁbrous tissue were apparently
observed. This gave an additional support that the methanolic
extract of L. styraciﬂua may exert an antiﬁbrotic effect beside
its role as hepatoprotective and antioxidant through improv-
ing liver function enzymes and oxidative stress markers.
Conversely, silymarin failed to improve the histopathological
picture of the liver where the liver still showed a marked degree
of ﬁbrosis, inﬂammation and steatosis.
a b
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e f
Figure 2 Photomicrographs of H&E and Masson’s trichrome stained liver sections (100·) of control (a and b), control treated with
250 mg/kg b.wt. of L. styraciﬂua methanolic extract (c and d), control treated with 500 mg/kg b.wt. of L. styraciﬂua methanolic extract
(e and f).
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activities exhibited by LSE closely approached those of sily-
marin necessitating a deeper phytochemical exploration of its
bioactive constituents.
3.2. Phytochemical investigation
3.2.1. Total phenolic content
The content of total phenolics determined colorimetrically in
the methanolic extract of the leaves of L. stryaciﬂua amounted
to 111.5 mg GAE/g extract.
3.2.2. Isolated phenolic compounds
Fractionation of LSE resulted in isolation of seven phenolic
compounds (1–7) (Fig. 1). All of these were identiﬁed based
on chromatographic, chemical and spectroscopic analyses as
well as through comparison with published data.Compound (1) was obtained as an off white amorphous
powder (69 mg); on co-chromatography (PC) alongside an
authentic sample of gallic acid, it appeared as a violet spot
under UV and blue color with ferric chloride T.S. Rf (·100)
78 (BAW) and 54 (6% acetic acid). Compound (1) was identi-
ﬁed as gallic acid.
Compound (2) was obtained as white amorphous powder
(56 mg) that appeared as a violet spot under UV and turns blue
upon spraying with ferric chloride T.S.; Rf (·100, PC) 12
(BAW) and 0 (6% acetic acid). UV Spectral data kmax (nm)
MeOH: 272. 1H-NMR spectral data d (ppm) (MeOD):
indicates that this tannin forms an anomer mixture (a- and
b-anomers) and that it possesses two galloyl groups with
signals at 7.03, 6.97 (s, 1H each, a-anomer) and 7.04, 6.76 (s,
1H each, b-anomer) and a valoneoyl group (7.3, 6.54, 6.36
[s, 1H each (a-anomer); 7.5, 6.55, 6.3 (s, 1H each,
(b-anomer)]) were observed together with signals of the glucose
moiety at 5.38 (1H, d, J= 2.5 Hz, H-1), 5.0 (1H, dd, J= 7.5 &
fe
c d
a b
g h
Figure 3 Photomicrographs of H&E and Masson’s trichrome stained liver sections (100·) of CCl4 group (a and b), CCl4 treated with
250 mg/kg b.wt. of L. styraciﬂua methanolic extract (c and d), CCl4 treated with 500 mg/kg b.wt. of L. styraciﬂua methanolic extract
(e and f), CCl4 treated with silymarin (g and h).
124 H.H. Eid et al.3.5 Hz, H-2), 5.7 (1H, t, J= 7.5 Hz, H-3), 4.88 (m, H-4), 4.57
(m, H-5), 5.12 (m, H-6) (a-anomer) and at 6.02 (1H, d,
J= 7.5 Hz, H-1), 5.81 (1H, t, J= 7.5 Hz, H-2), 5.91 (1H,
t, J= 7.5 Hz, H-3), 5.72 (1H, H-4), 4.44 (d, H-5), 3.84 (m,
H-6) (b-anomer). On the basis of the above evidence, the
structure of compound (2) was elucidated as isorugosin B.5
Compound (3) was isolated as an amorphous off-white
powder (44 mg), which appeared violet under UV light. It gave
blue color after spraying with ferric chloride T.S. Its Rf (PC)
was 72 (6% acetic acid) and 34 (BAW). UV Spectral data kmax
(nm) MeOH, 278 revealed an ellagitannin molecule. 1H-NMR
spectral data d (ppm) (MeOD); signals of two hexahydroxy-
diphenoyl moieties (HHDP) appeared at 6.35 6.46, 6.75, 6.77(1H, each s) and one galloyl moiety at 6.93 (2H, s). Those of
a, b-anomeric protons of glucose appeared at:5.23 (1H, d,
J= 2.5 Hz, H-1a), 4.85 (1H, d, J= 8 Hz, H-1b), 5.11 (1H,
t, J= 8 Hz, H-3a), 5.05 (1H, t, J= 8 Hz, H-3b), 4.72 (1H,
dd, J= 8 & 2.5 Hz, H-2a), 4.45 (1H, t, J= 8 Hz, H-2 b),
3.18–3.83 (m, overlapping other sugar and hydroxyl proton
signals). Compound (3) was isolated in a mixture form of
alpha and beta linkage and identiﬁed as casuarictin.50
Compound (4) was obtained as a pale yellow amorphous
powder (51 mg) that appeared as a dark purple spot on PC
under UV light changing to yellow upon exposure to ammonia
vapors and stained dirty green on spraying with ferric chloride
T.S. with Rf (·100): 70.9 (BAW) and 19.3 (6% acetic acid). UV
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MeOH/NaOAc/H3BO3 (262, 379), MeOH/AlCl3 (273, 309,
364), MeOH/AlCl3/HCl (259, 355).
1H NMR data (MeOD):
d ppm 3.1–3.7 (m, sugar protons), 5.4 (1H, d, J= 7.5 Hz glu-
cose H-100), 6.1 (1H, d, J= 2.5 Hz, H-6), 6.3 (1H, d,
J= 2.5 Hz, H-8), 6.8 (1H, d, J= 6.6 Hz, H-50), 7.54 (1H,
dd, J= 2.1, 6.6 Hz, H-60) and 7.45 (1H, d, J= 2.1, H-20).
13C NMR data: d ppm 156.7 (C-2), 133.7 (C-3), 177.9 (C-4),
161.7 (C-5), 99.1 (C-6), 164.6 (C-7), 94 (C-8), 156.8 (C-9),
104.4 (C-10), 121.6 (C-10), 116.6 (C-20), 145.3 (C-30), 148.9
(C-40), 115.7 (C-50), 122.1 (C-60), 101.3 (C-100), 74.5 (C-200), 78
(C-300), 70.3 (C-400), 76.9 (C-500) and 61.4 (C-600). The structural
formula of compound (4) was established as quercetin-3-O-
b-4C1-glucopyranoside.
51
Compound (5) was obtained as yellow powder (32 mg) that
appeared as a dark purple spot on PC under UV light, turning
yellow when fumed with NH3. Rf (·100) 54 (BAW) and 42 (6%
acetic acid). On spraying with ferric chloride T.S., it was
stained green. The UV absorption spectrum in MeOH exhib-
ited two major bands at kmax (MeOH) 259, 363 nm indicating
a ﬂavonol nucleus. 1H-NMR (MeOD) spectral data showed:
signals of aglycone moiety d (ppm) at 6.18 (1H, d,
J = 2.1 Hz, H-6), 6.35 (1H, d, J = 2.1 Hz, H-8), 6.93 (2H, s,
H-20, H-60); and sugar moiety d (ppm) at 5.2 (d, J = 2.1 Hz,
H-100), 3.1–3.9 (m, sugar protons) and 0.95 (3H, d,
J = 6.2 Hz, H-600). 13C NMR data: d ppm, aglycone: 157.1
(C-2), 134.9 (C-3), 178.3 (C-4), 161.7 (C-5), 98.7 (C-6), 164.5
(C-7), 93.4 (C-8), 158.1 (C-9), 104.5 (C-10), 120.5 (C-10),
108.3 (C-20), 145.4 (C-30), 136.5 (C-40), 145.4 (C-50), 108.3 (C-
60); rhamnose moiety: 102.2 (C-100), 70.5 (C-200), 70.7 (C-300),
72.0 (C-400), 70.1 (C-500) and 16.3 (C-600). Compound (5)
was identiﬁed as myricetin-3-O-a-L-1C4-rhamnopyranoside
(myricetrin).52
Compounds (6) (54 mg) and (7) (36 mg) were identiﬁed
through matching their spectroscopic and physical data with
those published in the literature and conﬁrmed by comparison
with those obtained for authentic samples of quercetin and
myricetin, respectively.
The chromatographic investigation of the LSE which
exhibited antioxidant and hepatoprotective activities resulted
in isolation of seven phenolic compounds viz., gallic acid (1),
isorugosin B (2), casuarictin (3), quercetin-3-O-b-D-4C1-
glucopyranoside (4), myricetin-3-O-a-L-1C4-rhamnopyranoside
(myricetrin) (5), quercetin (6) and myricetin (7).
Our results are in accordance with those of Spencer et al.14
who isolated gallic acid from the bark and sapwood of L.
styraciﬂua L. Likewise isoquercetrin,7 casuarictin,3 isorugosin
B5 have been previously isolated from L. formosana
leaves. On the contrary, Hanato et al.5 isolated myricetin
3-O-glucoside from L. formosana leaves, whereas myricetin-
3-O-a-L-1C4-rhamnopyranoside (myricetrin) was herein
isolated from the extract of those of L. styraciflua L.
The antioxidant and hepatoprotective activities of the
tested extract could be attributed to the compounds isolated
therefrom. Domitrovic´ et al.53 and Maalik et al.54 reported
that ﬂavonoids namely, quercetin can ameliorate acute liver
damage by acting as scavengers of free radicals, inhibiting
the inﬂammatory response, manifested by a decreased
deposition of fats in liver cells; thereby it protects liver cells
from ﬁbrosis and reduces plasma concentration of alanine
aminotransferase thus exerting high antioxidant and anti-
inﬂammatory activities and antiﬁbrotic action and may bepartially responsible for beneﬁcial effects observed in injured
liver tissue. In addition, Pandy et al.55 mentioned that myrice-
tin signiﬁcantly protected the membrane lipid peroxidation
and protein oxidation subjected to oxidative stress, as evi-
denced by a decrease in the MDA level and protein carbonyl
content. Also, the antioxidant activity may also be attributed
to isoquercitrin which decreased the oxidative stress markers,
such as levels of ROS, protein carbonylation and lipid perox-
idation, and inducing the superoxide dismutase activity in
order to increase survival of cells and leading to protection
of the cells.56 On the other hand, the antihepatotoxic activity
of tannins had been evidenced by Hikino et al.57, who reported
that the hydrolysable and condensed tannins generally inhib-
ited the action of glutamic–pyruvic transaminase (ALT) and
the increase of the number of the galloyl grouping potentiated
the antihepatotoxic activity. In hydrolyzable tannins, increase
of the galloyl grouping led to potentiation of the enzyme inhi-
bitory activity such as casuarictin, while in the low-molecular
weight polyphenols such as gallic acid, the presence of
1,2dihydroxy or 1,2,3-trihydroxy grouping on the benzene ring
appears to be required.57 Furthermore, gallic acid was
reported to protect the integrity of plasma membrane and to
increase the regenerative and reparative capacity of the liver58;
in addition, it showed protective effects against serum GPT
and GOT which are released into the blood when plasma
membrane of hepatic cells is damaged.59
Therefore, it can be deduced that the antioxidant effects of
the phenolic components of the methanolic extract of L. styr-
aciflua leaves (LSE) effectively decreased oxidative stress and
consequently produced a signiﬁcant hepatoprotective activity
in liver damaged animals. Therefore, it was deemed necessary
to quantify these compounds within the extract to facilitate its
standardization, as a requirement to guarantee its therapeutic
value.
3.2.3. Standardization of LSE by RP-HPLC
3.2.3.1. Validation of the quantiﬁcation method. The calibration
curves indicated good linearity (R2 = 0.9896 and 0.9962),
within the tested range for gallic acid and quercetin
respectively.
The limit of detection (LOD) (0.0534, and 0.01268 mg/ml)
and limit of quantitation (LOQ) (0.1619, 0.0384 mg/ml) were
determined for gallic acid and quercetin, respectively.
The analytical precision from the results of intra-day (six
times a day) and inter-day (over three consecutive days) was
calculated as shown in Table 1. The relative standard devia-
tions (RSDs), which were both less than 5% for gallic acid
and quercetin, respectively lie within the same range which
were both less than 5%. The stability tests revealed that the
RSDs (3.967%, 3.7333%) for the determined compounds were
also less than 5% and the mean recovery (mean ± SD) of
gallic acid and quercetin was 98.99 ± 0.3211 and
102.4646 ± 0.0268 (RSD are 0.8041% and 0.7552%), respec-
tively. The results indicated that the method was precise for
simultaneous determination of the two components.
3.2.3.2. Determination of polyphenolic compounds in LSE by
HPLC analysis. Seven phenolic compounds viz., (1) to (7) were
identiﬁed and quantiﬁed in LSE for standardization purpose,
based on comparison with isolated compounds. Quercetin gly-
cosides were quantiﬁed as quercetin (6), whereas pyrogallol
tannins were quantiﬁed as gallic acid (1). Compounds 1–3 were
126 H.H. Eid et al.calculated as gallic acid, amounting to 33.84 mg /gram extract
while compounds 4–7 were calculated as quercetin and reached
up to 0.88 mg/g extract.
The development of a simple, precise validated RP-HPLC-
UV procedure will facilitate the standardization of the
methanolic extract of L. styraciﬂua leaves. The proposed
method represents a contribution to quantiﬁcation of active
phenolics in this extract, using quercetin and gallic acid as
markers. On the other hand, the previous ﬁndings revealed
the value of the analyzed extract as a promising source of
health promoting polyphenols and encourage their inclusion
in food supplements as alternatives to the traditional leaf
extracts.
4. Conclusion
Results acquired from the present study suggest that oral
administration of the methanolic extract of the leaves of L.
styraciﬂua L. obviously prevents oxidative damage to major
biomolecules, decreases severity of ﬁbrosis, normalizes hepatic
cell architecture and affords signiﬁcant protection against
CCL4-induced oxidative stress and liver damage in rats.
The phenolic compounds isolated from the extract, and
quantiﬁed by a validated RP-HPLC method, might be respon-
sible for its activity either individually or in mixture through
synergism. Hence, L. styraciflua leaves enriched with such
effective antioxidants could be considered as a promising
source of natural hepatoprotective agents. However, further
application in medical practice should be conﬁrmed by convey-
ing pharmacological and preliminary placebo-controlled clini-
cal studies.
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